Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study.
Drug Saf
; 41(8): 797-806, 2018 08.
Article
en En
| MEDLINE
| ID: mdl-29671224
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vigilancia de Productos Comercializados
/
Antipsicóticos
/
Trastorno Bipolar
/
Personal de Salud
/
Unión Europea
/
Aripiprazol
Tipo de estudio:
Etiology_studies
/
Evaluation_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2018
Tipo del documento:
Article